drugset / Trial / NCT06253429
Alpha-lipoic Acid in Diabetic Nephropathy
RandomizedParallel-groupSingle-blindSupportive care
Summary
Endothelial dysfunction in diabetes is a central event in the pathogenesis of different microangioapthic changes. Nephropathy in patients with type 1 diabetes is a severe microvascular complication.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2024-01-31
- Completion
- 2024-02-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Thioctic Acid | Unknown | 300 mg | Oral |
| Comparator | Captopril | Small molecule | 25 mg | Oral |